Cargando…

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy

Detalles Bibliográficos
Autores principales:	Miri, Seyed Mohammad, Tafsiri, Elham, Cho, William Chi Shing, Ghaemi, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594476/ https://www.ncbi.nlm.nih.gov/pubmed/33132758 http://dx.doi.org/10.1186/s12935-020-01609-w

Ejemplares similares

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Modern Prometheus: editing the human genome with Crispr-Cas9
por: Kozubek, Jim
Publicado: (2016)

CRISPR-Cas systems: ushering in the new genome editing era
por: Perez Rojo, Fernando, et al.
Publicado: (2018)

Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections
por: Najafi, Sajad, et al.
Publicado: (2022)

An Insight into Modern Targeted Genome-Editing Technologies with a Special Focus on CRISPR/Cas9 and its Applications
por: Akram, Fatima, et al.
Publicado: (2022)

Bioethical issues in genome editing by CRISPR-Cas9 technology
por: AYANOĞLU, Fatma Betül, et al.
Publicado: (2020)

Harnessing CRISPR-Cas system diversity for gene editing technologies
por: McKay, Alexander, et al.
Publicado: (2021)

Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9
por: Agudelo, Daniel, et al.
Publicado: (2020)

Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing
por: Chen, Yangcan, et al.
Publicado: (2022)

CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
por: Azangou-Khyavy, Mohammadreza, et al.
Publicado: (2020)

Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapy
por: Afolabi, Lukman O, et al.
Publicado: (2021)

CRISPR-Cas technology a new era in genomic engineering
por: Parsaeimehr, Ali, et al.
Publicado: (2022)

Modern Trends in Plant Genome Editing: An Inclusive Review of the CRISPR/Cas9 Toolbox
por: Razzaq, Ali, et al.
Publicado: (2019)

Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

Edition of TFAM gene by CRISPR/Cas9 technology in bovine model
por: de Oliveira, Vanessa Cristina, et al.
Publicado: (2019)

Efficient Genome Editing Using CRISPR/Cas9 Technology in Chicory
por: Bernard, Guillaume, et al.
Publicado: (2019)

Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
por: Al-Sammarraie, Nadia, et al.
Publicado: (2021)

CRISPR/Cas based gene editing: marking a new era in medical science
por: Prasad, Kirti, et al.
Publicado: (2021)

Genome editing of pseudorabies virus in the CRISPR/Cas9 era: a mini-review
por: Wang, Hai-Ming, et al.
Publicado: (2023)

CRISPR/Cas9 system: a reliable and facile genome editing tool in modern biology
por: Javaid, Darakhshan, et al.
Publicado: (2022)

CRISPR/Cas9: A Robust Genome-Editing Tool with Versatile Functions and Endless Application
por: Zhang, Baohong
Publicado: (2020)

Correction to: Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

CRISPR/Cas9 genome editing technology in filamentous fungi: progress and perspective
por: Song, Runjie, et al.
Publicado: (2019)

Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology
por: Qiu, Yan, et al.
Publicado: (2021)

CRISPR-Cas gene editing technology and its application prospect in medicinal plants
por: Guo, Miaoxian, et al.
Publicado: (2022)

Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
por: Zhao, Ziyi, et al.
Publicado: (2021)

Application progress of CRISPR/Cas9 genome-editing technology in edible fungi
por: Zhang, Yan, et al.
Publicado: (2023)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy
por: Ju, Hyemin, et al.
Publicado: (2022)

Pathogen detection in the CRISPR–Cas era
por: Sashital, Dipali G.
Publicado: (2018)

CRISPR/Cas9-deaminase enables robust base editing in Rhodobacter sphaeroides 2.4.1
por: Luo, Yufeng, et al.
Publicado: (2020)

Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA
por: Zhang, Xianming, et al.
Publicado: (2022)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Genome Editing in Bacteria: CRISPR-Cas and Beyond
por: Arroyo-Olarte, Ruben D., et al.
Publicado: (2021)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing
por: Killian, Tobias, et al.
Publicado: (2017)

Targeted genome and epigenome editing using engineered TALE and CRISPR/Cas9 technologies
por: Gersbach, Charles A
Publicado: (2014)

 Yeast Still a Beast: Diverse Applications of CRISPR/Cas Editing Technology in S. cerevisiae 
por: Giersch, Rachael M., et al.
Publicado: (2017)

CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
por: Rahman, Mujeeb ur, et al.
Publicado: (2022)

A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases
por: Roshanravan, Neda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cqsd4nu3ch00dj1krnfnid7i2d